Trials / Completed
CompletedNCT05398510
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous/Subcutaneous Injection of SHR-2010 in Healthy Subjects: a Randomized, Double-blind, Dose-increasing, Placebo-controlled Phase I Clinical Trial
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to Evaluate the Safety, Tolerability and Pharmacokinetics pharmacodynamics of SHR-2010 by intravenously/subcutaneously in Healthy Subject.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-2010 injection | Treatment for intravenously: 6 subjects for SR-2010 injection. Treatment for subcutaneously: 8 subjects for SR-2010 injection. |
| DRUG | SHR-2010 injection placebo | Treatment for intravenously: 2 subjects for placebo. Treatment for subcutaneously: 2 subjects for placebo. |
Timeline
- Start date
- 2022-06-30
- Primary completion
- 2023-03-10
- Completion
- 2023-03-10
- First posted
- 2022-06-01
- Last updated
- 2023-03-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05398510. Inclusion in this directory is not an endorsement.